CC
CGEM icon

Corton Capital’s Cullinan Oncology CGEM Stock Holding History

Corton Capital’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$161K Buy
27,117
+5,405
+25% +$39.6K 0.4% 138
2025
Q2 		$163K Buy
21,712
+4,870
+29% +$39.1K 0.19% 269
2025
Q1 		$127K Buy
16,842
+4,898
+41% +$47K 0.42% 108
2024
Q4 		$145K Buy
+11,944
New +$172K 0.08% 305

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Corton Capital's CGEM Position: Q3 2025 in Review

Corton Capital increased its Cullinan Oncology (CGEM) stake by 25% in Q3 2025, buying an estimated $39.6K and bringing the position to 27,117 shares worth $161K. The position accounts for 0.4% of the portfolio, ranked #138.

Corton Capital first reported a position in CGEM in Q4 2024 and has held it in 4 quarters since. The position peaked at $163K in Q2 2025. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • Corton Capital held 27,117 shares of Cullinan Oncology worth $161K as of Q3 2025.
  • Corton Capital bought 5,405 Cullinan Oncology shares in Q3 2025, an estimated $39.6K.
  • Cullinan Oncology made up 0.4% of Corton Capital's portfolio in Q3 2025, its #138 holding.
  • Corton Capital first reported a position in Cullinan Oncology in Q4 2024 and has held it in 4 quarters since.
  • Corton Capital's Cullinan Oncology position peaked at $163K in Q2 2025.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.